Healthcare of Ontario Pension Plan (HOOPP) Trust Fund’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-60,500
Closed -$1.02M 969
2023
Q4
$1.02M Hold
60,500
﹤0.01% 767
2023
Q3
$707K Sell
60,500
-9,000
-13% -$120K ﹤0.01% 747
2023
Q2
$934K Sell
69,500
-11,500
-14% -$165K ﹤0.01% 749
2023
Q1
$1.34M Sell
81,000
-158,600
-66% -$2.62M 0.01% 659
2022
Q4
$4.46M Buy
239,600
+132,600
+124% +$2.04M 0.02% 499
2022
Q3
$1.37M Buy
+107,000
New +$1.27M 0.01% 814

Other funds holding CPRX

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's CPRX Position: Q1 2024 in Review

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund sold out of Catalyst Pharmaceutical (CPRX) in Q1 2024, closing a stake of 60,500 shares — an estimated $1.02M sold.

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund first reported a position in CPRX in Q3 2022 and held it in 6 quarters. The position peaked at $4.46M in Q4 2022. 269 funds tracked by Wall St. Rank hold CPRX as of Q1 2024.

  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund reported no remaining Catalyst Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund sold 60,500 Catalyst Pharmaceutical shares in Q1 2024, an estimated $1.02M.
  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund first reported a position in Catalyst Pharmaceutical in Q3 2022 and held it in 6 quarters.
  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's Catalyst Pharmaceutical position peaked at $4.46M in Q4 2022.
  • 269 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2024.

Based on Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's 13F filing for Q1 2024, filed 13 May 2024.